Drug Development Algorithms: Is AI the Game-Changer? is a 120-minute webinar exploring how AI, machine learning, and deep learning are reshaping drug development—from target identification to clinical trials and approvals. Experts will share insights, case studies, and panel discussions on AI’s transformative impact.
Understand AI's role in revolutionizing drug development from discovery to approval.
Explore how AI, quantum computing, and high-performance computing (HPC) enhance clinical trial efficiency.
Learn from case studies showcasing successful AI applications in regulatory decision-making and real-world evidence studies.
Foster collaboration between pharmaceutical experts, biotech leaders, researchers, and AI innovators.
AI is transforming the drug development process by reducing costs, improving efficiency, and enhancing success rates. Key benefits include:
Accelerating drug discovery – Identifying novel drug candidates faster.
Optimizing clinical trial designs – Enhancing patient recruitment and success rates.
Personalized medicine – Leveraging AI-driven insights for targeted therapies.
Improving regulatory decision-making – Using AI for compliance and risk assessment.
This webinar is ideal for:
Drug development professionals, scientists, and researchers.
Bioinformaticians, computational biologists, and AI specialists.
Pharmaceutical and biotechnology executives exploring AI integration.
Academics and students in bioinformatics, computational biology, and AI.
Investors and professionals seeking insights into AI’s role in medicine.
Overview of the Agenda and Speakers
Ed Addison, Executive Chairman, Cloud Pharmaceuticals, Inc.
Istvan Enyedy, Senior Principal Scientist, UCB
Nicholas Wisniewski, Vice President, Head of Bioinformatics and Data Science, Stemson Therapeutics
Zoran Krunic, Senior Manager of Data Science, Amgen
Monica Jain, Director, R&D Data Science, Johnson & Johnson Innovative Medicine
Sponsored Session Featuring Cutting-edge AI Applications
Final Insights and Future Outlook
We encourage active participation! Submit your questions in advance to engage with our expert panel.